يعرض 1 - 10 نتائج من 105 نتيجة بحث عن '"GLCA"', وقت الاستعلام: 1.25s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المؤلفون: Li, JialianAff1, Aff2, Aff3, Liu, YanlaiAff1, Aff2, Hu, LitaoAff1, Aff2, Xu, RuiruiAff1, Aff2, Zhang, WeijiaoAff1, Aff2, Hu, ShanAff1, Aff2, Wang, YangAff1, Aff2, Du, GuochengAff1, Aff2, Kang, ZhenAff1, Aff2, IDs4339302400238y_cor9

    المصدر: Systems Microbiology and Biomanufacturing. 4(3):895-905

  2. 2
  3. 3
  4. 4
  5. 5
    كتاب إلكتروني

    المؤلفون: Li, Jin-pingAff7

    المساهمون: Taniguchi, Naoyuki, editorAff1, Honke, Koichi, editorAff2, Fukuda, Minoru, editorAff3, Narimatsu, Hisashi, editorAff4, Yamaguchi, Yoshiki, editorAff5, Angata, Takashi, editorAff6

    المصدر: Handbook of Glycosyltransferases and Related Genes. :965-975

  6. 6
  7. 7
  8. 8
  9. 9
    كتاب إلكتروني

    المؤلفون: Habuchi, OsamiAff3

    المساهمون: Taniguchi, Naoyuki, editorAff1, Honke, Koichi, editorAff1, Fukuda, Minoru, editorAff2, Clausen, Henrik, editor, Furukawa, Kiyoshi, editor, Hart, Gerald W., editor, Kannagi, Reiji, editor, Kawasaki, Toshisuke, editor, Kinoshita, Taroh, editor, Muramatsu, Takashi, editor, Saito, Masaki, editor, Shaper, Joel H., editor, Sugahara, Kazuyuki, editor, Tabak, Lawrence A., editor, Van den Eijnden, Dirk H., editor, Yanagishita, Masaki, editor, Dennis, James W., editor, Furukawa, Koichi, editor, Hirabayashi, Yoshio, editor, Kawakita, Masao, editor, Kimata, Koji, editor, Lindahl, Ulf, editor, Narimatsu, Hisashi, editor, Schachter, Harry, editor, Stanley, Pamela, editor, Suzuki, Akemi, editor, Tsuji, Shuichi, editor, Yamashita, Katsuko, editor

    المصدر: Handbook of Glycosyltransferases and Related Genes. :413-417

    Degree: M.D., Ph.D.
    Ph.D.

  10. 10

    المساهمون: Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 (RNMCD), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Recherche translationnelle sur le diabète - U 1190 (RTD), University of Antwerp (UA), Antwerp University Hospital [Edegem] (UZA), ANR-16-RHUS-0006,PreciNASH,PreciNASH(2016), ANR-10-LABX-0046,EGID,EGID Diabetes Pole(2010), European Project: 694717,H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) ,ImmunoBile(2016), European Project: 32591,HEPADIP, European Project: 305707,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,RESOLVE(2013), Derudas, Marie-Hélène, PreciNASH - - PreciNASH2016 - ANR-16-RHUS-0006 - RHUS - VALID, EGID Diabetes Pole - - EGID2010 - ANR-10-LABX-0046 - LABX - VALID, Bile acid, immune-metabolism, lipid and glucose homeostasis - ImmunoBile - - H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) 2016-09-01 - 2021-08-31 - 694717 - VALID, Hepatic and adipose tissue and functions in the metabolic syndrome - HEPADIP - 32591 - OLD, A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities, hypertriglyceridemia and low HDL-cholesterol - RESOLVE - - EC:FP7:HEALTH2013-01-01 - 2017-12-31 - 305707 - VALID, Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires (RNMCD - U1011), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille

    المصدر: JHEP Reports Innovation in Hepatology
    JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
    JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100222. ⟨10.1016/j.jhepr.2020.100222⟩
    JHEP Reports
    JHEP Reports, Vol 3, Iss 2, Pp 100222-(2021)

    مصطلحات موضوعية: GHDCA, glycolithocholic acid, taurohyodeoxycholic acid, OGTT, oral glucose tolerance test, GUDCA, glycoursodeoxycholic acid, TCDCA, FXR, farnesoid-X-receptor, UDCA, ADA, American Diabetes Association, IR, insulin resistance, GCA, glycocholic acid, THDCA, taurohyodeoxycholic acid, HCA, T2D, LCA, lithocholic acid, HCA, hyocholic acid, DCA, TCDCA, taurochenodeoxycholic acid, GCDCA, glycochenodeoxycholic acid, LCA, NASH, GCDCA, GHCA, glycohyocholic acid, TCA, cholic acid, [SDV] Life Sciences [q-bio], FPG, glycoursodeoxycholic acid, FXR, deoxycholic acid, glycocholic acid, non-alcoholic steatohepatitis, TDCA, taurodeoxycholic acid, HbA1c, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, Translational study, oral glucose tolerance test, digestive system, BA, UDCA, ursodeoxycholic acid, HDCA, glycochenodeoxycholic acid, TUDCA, tauroursodeoxycholic acid, NAFLD, OGTT, taurochenodeoxycholic acid, NAFL, non-alcoholic fatty liver, GCA, FPG, fasting plasma glycaemia, GDCA, glycodeoxycholic acid, GLCA, glycolithocholic acid, C4, bile acids, glycodeoxycholic acid, nutritional and metabolic diseases, HOMA2, homeostatic model assessment 2, hyocholic acid, digestive system diseases, farnesoid-X-receptor, DCA, deoxycholic acid, GUDCA, IR, TLCA, taurolithocholic acid, American Diabetes Association, CDCA, Human medicine, ABOS, Biological Atlas of Severe Obesity, HDCA, hyodeoxycholic acid, [SDV]Life Sciences [q-bio], HOMA2, taurodeoxycholic acid, taurolithocholic acid, C4, 7alpha-hydroxy-4-cholesten-3-one, insulin resistance, Biological Atlas of Severe Obesity, taurohyocholic acid, MAFLD, metabolic associated fatty liver disease, CA, cholic acid, CA, THCA, GHDCA, glycohyodeoxycholic acid, Diabetes, TLCA, glycohyocholic acid, ursodeoxycholic acid, TUDCA, TDCA, fasting plasma glycaemia, lithocholic acid, NAFL, BA, bile acids, chenodeoxycholic acid, non-alcoholic fatty liver, type 2 diabetes, ABOS, Research Article, NAFLD, non-alcoholic fatty liver disease, TCA, taurocholic acid, MAFLD, taurocholic acid, CDCA, chenodeoxycholic acid, metabolic associated fatty liver disease, glycated haemoglobin, homeostatic model assessment 2, Obesity, lcsh:RC799-869, tauroursodeoxycholic acid, 7alpha-hydroxy-4-cholesten-3-one, non-alcoholic fatty liver disease, THDCA, hyodeoxycholic acid, ADA, GDCA, lcsh:Diseases of the digestive system. Gastroenterology, HbA1c, glycated haemoglobin, GHCA, glycohyodeoxycholic acid, THCA, taurohyocholic acid, GLCA

    وصف الملف: application/pdf